US Astigmatism Market Research Report: By Type (Myopic Astigmatism, Hyperopic Astigmatism, others), By Treatment (Corrective Lenses, Orthokeratology (Ortho-K), Surgeries, others) and By End User (Hospital, Clinics, others) - Forecast to 2035

US Astigmatism Market Overview:

As per MRFR analysis, the US Astigmatism Market Size was estimated at 294.63 (USD Million) in 2023. The US Astigmatism Market Industry is expected to grow from 320(USD Million) in 2024 to 900 (USD Million) by 2035. The US Astigmatism Market CAGR (growth rate) is expected to be around 9.857% during the forecast period (2025 - 2035).

Key US Astigmatism Market Trends Highlighted

The US astigmatism market is increasingly influenced by the growing awareness of vision health and advancements in eyecare technology. One key market driver is the rise in the prevalence of astigmatism, with studies indicating that nearly one-third of the US population experiences some degree of this condition. This has led to greater demand for corrective lenses and procedures, highlighting the importance of regular eye examinations. Furthermore, the increasing adoption of digital devices has prompted concerns about vision problems, making the promotion of eye health fundamental in personal and professional settings. Opportunities to be explored in the US market include the expansion of telehealth services for eye care, which have gained traction especially following the COVID-19 pandemic.This mode of service delivery allows for more accessible consultations and follow-ups for individuals seeking correction options for astigmatism. Additionally, the growing trend of personalized medicine offers avenues for customized lenses and procedures, promising better outcomes for patients. Recent trends in the US market also point toward a shift in consumer preferences, with many opting for contact lenses over glasses as a convenience and aesthetic choice. Innovations in contact lens technology, such as extended wear and toric lenses specifically designed for astigmatism, are becoming more prevalent, allowing for broader market reach. Moreover, the commitment to providing education on eye health and prevention of vision issues is paving the way for stronger engagement between consumers and eyecare professionals, making it clear that the future of the US astigmatism market is not just focused on correction but also on comprehensive eye health management.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

US Astigmatism Market Drivers

Increasing Prevalence of Astigmatism in the US Population

The rising incidence of astigmatism among the population in the United States serves as a significant driver for the US Astigmatism Market Industry. According to the American Academy of Ophthalmology, approximately 28.3% of the US population has some degree of astigmatism. This translates to more than 85 million individuals potentially requiring corrective measures, whether through lenses or surgical interventions. As awareness increases through educational campaigns and screenings conducted by established organizations such as the Centers for Disease Control and Prevention (CDC), there is likely to be a corresponding rise in consultation and treatment, thereby driving market growth.The projected increase in the case numbers directly correlates with the expanded market potential, as individuals seek to correct their vision. Furthermore, the growing tendency of individuals to prioritize eye health through routine check-ups adds to the demand for astigmatism solutions. This trend is further amplified by governmental and healthcare initiatives aiming to reduce undiagnosed vision conditions across the states.

Technological Advancements in Vision Correction

The advent of innovative technology in the vision correction sector, particularly for astigmatism, significantly contributes to market expansion within the US Astigmatism Market Industry. Recent developments in laser technologies, such as Laser-Assisted in Situ Keratomileusis (LASIK) and wavefront-guided laser treatments, have improved the precision and effectiveness of astigmatism correction surgeries, enhancing patient outcomes. The Food and Drug Administration (FDA) has recently approved several cutting-edge devices, stimulating healthy competition in the marketplace, leading to more options being available for consumers.With advancements reducing recovery times and increasing success rates, many patients are likely to opt for surgical correction over traditional lenses. The increased accessibility of these advanced technologies through partnerships between hospitals and leading medical device companies enhances market visibility and growth prospects.

Rising Awareness About Eye Health and Regular Screenings

Growing public awareness regarding the significance of eye health and the importance of regular screenings is fostering an environment conducive to growth in the US Astigmatism Market Industry. Surveys conducted by the American Optometric Association indicate that the proportion of adults who have undergone comprehensive eye exams has increased by nearly 20% over the past five years, emphasizing that more consumers are becoming proactive about their vision health.Initiatives from health campaigns and educational programs by reputable organizations are central in encouraging regular eye examinations, thereby identifying cases of astigmatism early. Consequently, with earlier identification, more patients are entering into consultations and seeking treatment options for their conditions, positively impacting the market's growth trajectory.

Increasing Investment in Eye Care Facilities

The burgeoning investment in eye care facilities and specialized clinics in the United States is another prominent driver pushing the growth of the US Astigmatism Market Industry. Data from the American Hospital Association reveals that there was a 15% increase in the establishment of eye care centers in urban areas over a two-year period. Such facilities are increasingly equipped with the latest diagnostic tools and treatment technologies, which not only enhance patient care but also cater to the growing demand for astigmatism correction.With improved access to eye care services, more individuals are likely to seek treatment options, contributing to market growth. The establishment of these facilities, often backed by health insurance policies, has made treatments considerably more accessible to a wider demographic.

US Astigmatism Market Segment Insights:

Astigmatism Market Type Insights

The US Astigmatism Market is characterized by diverse Type segments that cater to different aspects of this visual condition, primarily including Myopic Astigmatism, Hyperopic Astigmatism, and a variety of others. Myopic Astigmatism, which occurs when the eye is elongated, causing blurry vision for distant objects, plays a significant role in this market due to its prevalence among the younger population. This segment often results in patients needing corrective lenses or procedures, contributing to a considerable share of the market. Hyperopic Astigmatism, conversely, involves a shorter eye or a cornea that is too flat, which leads to blurred vision for near objects.With an aging population in the US, more individuals are experiencing this type of astigmatism, thus increasing the demand for corrective measures and driving innovations in eye care technologies. The other categories present within this segment often include irregular astigmatism, which can arise post-surgery or due to keratoconus, signaling a need for specialized treatment options and creating opportunities for advancements in surgical techniques and devices. Overall, each type of astigmatism addresses distinct visual impairments and creates unique market dynamics, influencing both patient needs and industry responses in the evolving US Astigmatism Market.The increasing awareness and diagnosis of these conditions further expands the market's potential, as individuals seek improved quality of life through effective intervention solutions.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Astigmatism Market Treatment Insights

The Treatment segment of the US Astigmatism Market encompasses various methods aimed at correcting vision issues caused by astigmatism. Corrective lenses, including glasses and contact lenses, play a significant role in managing this condition, as they provide an immediate and effective solution for many individuals. Orthokeratology, or Ortho-K, is gaining traction as a non-surgical option, particularly among children and young adults, by employing specially designed contact lenses to reshape the cornea overnight, thus offering clear vision during the day without needing lenses.Surgical procedures such as LASIK and PRK represent a notable part of this market, often preferred by patients seeking a more permanent solution. These procedures have seen advancements in technology, improving safety and recovery times. Additionally, other treatment methods may include therapeutic options tailored to individual needs. With an increasing awareness of vision health and a growing aging population in the US, the demand for effective treatment options for astigmatism continues to rise, indicating robust growth potential within this segment.Overall, the US Astigmatism Market segmentation highlights the diverse approaches available for treating astigmatism, along with significant shifts towards innovative and less invasive methods that enhance patient satisfaction.

Astigmatism Market End User Insights

The US Astigmatism Market, particularly in the End User segment, showcases diverse and significant applications across various healthcare settings. Hospitals represent a vital component, as they provide comprehensive services for diagnosis and treatment, thereby facilitating advanced care for astigmatism patients. Clinics also play a crucial role, often serving as the first point of contact for individuals seeking eye care, thereby driving early diagnosis and management, contributing to better outcomes. The presence of specialized eye care centers and other facilities further enriches the market, addressing the growing demand for astigmatic treatments.Overall, the End User segment is characterized by the increasing emphasis on personalized eye care and the adoption of innovative technologies, which stimulate market growth, while patient preferences for convenience and accessibility shape the dynamics within this segment. As vision correction treatments become more prevalent, the competition among hospitals, clinics, and other entities intensifies, creating a robust ecosystem surrounding the US Astigmatism Market. Various trends, such as advancements in healthcare technology and an increasing focus on patient-centered care, continue to influence this landscape, presenting opportunities for growth and improvement in the effectiveness of treatments.

US Astigmatism Market Key Players and Competitive Insights:

The US Astigmatism Market is characterized by a dynamic landscape shaped by the growing prevalence of refractive errors, advances in optical technologies, and increasing awareness among the population regarding vision health. The competitive insights of this market reveal a range of key players striving to innovate their offerings, focusing on not only the quality of products but also on effective marketing strategies to enhance customer reach. Companies within this space are required to adapt rapidly to changing consumer preferences and technological advancements, thereby intensifying competition. The holistic approach to developing diagnostic tools, corrective lenses, and surgical interventions has led to significant growth opportunities. Firms are increasingly investing in research and development to introduce novel solutions aimed at improving patient outcomes while expanding their market share.Bausch and Lomb stands out in the US Astigmatism Market due to its robust portfolio of products and a strong brand presence that resonates with both consumers and healthcare professionals. This company is recognized for its high-quality contact lenses and care solutions, which cater specifically to the needs of individuals suffering from astigmatism. The strengths of Bausch and Lomb lie in its established reputation for innovation, having introduced cutting-edge products that incorporate advanced lens technologies. Their effective distribution channels and partnerships with eye care professionals have further solidified their position in the market. The company benefits from a wide-reaching marketing strategy that emphasizes customer education regarding eye health, thus enhancing trust and loyalty among consumers within the US.Santen Pharmaceutical has also made significant strides in the US Astigmatism Market, focusing primarily on therapeutic solutions for eye disorders. The company’s key products include a range of prescription eye drops aimed at providing relief for various eye conditions, including those associated with astigmatism. Santen’s strengths encompass its commitment to research and innovation, which has enabled the development of specialized products tailored for the US market. The company has increased its market presence through strategic mergers and acquisitions, allowing it to expand its portfolio and access new customer segments. Santen’s dedication to understanding patient needs and their collaboration with healthcare providers further enhance their offerings in this competitive landscape. As a result, they have established themselves as a reliable choice for patients seeking effective treatments for astigmatism-related issues.

Key Companies in the US Astigmatism Market Include:

Bausch and Lomb

Santen Pharmaceutical

Topcon Corporation

CooperVision

Medtronic

Acuity Brands

Carl Zeiss

EssilorLuxottica

Hoya Corporation

Alcon

Rayner Surgical

Abbott Laboratories

Nidek Co

Johnson and Johnson

US Astigmatism Market Industry Developments

Recent developments in the US Astigmatism Market have highlighted significant advancements and shifts among key players. For example, in October 2023, Alcon announced a breakthrough in its lens technology aimed at enhancing vision for those with astigmatism, showcasing ongoing innovation in the field. In September 2023, CooperVision launched a new line of toric contact lenses designed specifically for astigmatism, further solidifying their commitment to addressing this condition. Additionally, EssilorLuxottica reported growth in its product offerings targeting astigmatism, which supported a rise in their market valuation during Q3 2023. Mergers and acquisitions continue to shape this market, with Santen Pharmaceutical acquiring a US-based technology company focused on developing astigmatism correction devices in August 2023. This acquisition is expected to bolster Santen’s presence in the US market. The influence of these companies, along with regulatory support for advanced eye care technologies, has positioned the US astigmatism market for substantial growth. Major players like Bausch and Lomb, Hoya Corporation, and Johnson and Johnson are also evolving their strategies to meet the increasing demand for innovative solutions in astigmatism correction.

US Astigmatism Market Segmentation Insights

Astigmatism Market Type Outlook

Myopic Astigmatism

Hyperopic Astigmatism

others

Astigmatism Market Treatment Outlook

Corrective Lenses

Orthokeratology (Ortho-K)

Surgeries

others

Astigmatism Market End User Outlook

Hospital

Clinics

others

Report Scope:

Report Attribute/Metric Source:	Details
MARKET SIZE 2018	294.63(USD Million)
MARKET SIZE 2024	320.0(USD Million)
MARKET SIZE 2035	900.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	9.857% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	Bausch and Lomb, Santen Pharmaceutical, Topcon Corporation, CooperVision, Medtronic, Acuity Brands, Carl Zeiss, EssilorLuxottica, Hoya Corporation, Alcon, Rayner Surgical, Abbott Laboratories, Nidek Co, Johnson and Johnson
SEGMENTS COVERED	Type, Treatment, End User
KEY MARKET OPPORTUNITIES	Growing demand for corrective lenses, Advancements in laser correction technology, Rising awareness of eye health, Increasing prevalence of myopia, Expansion of tele-optometry services
KEY MARKET DYNAMICS	rising prevalence of astigmatism, increasing awareness of vision care, advancements in corrective technologies, growing demand for personalized solutions, expanding optical retail market
COUNTRIES COVERED	US